CAS 1095382-05-0
:CCT-137690
Description:
CCT-137690, with the CAS number 1095382-05-0, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain protein kinases, which play crucial roles in various cellular processes, including cell growth and division. The compound is characterized by its unique molecular structure, which contributes to its specificity and efficacy in inhibiting target enzymes. CCT-137690 has been studied for its potential use in cancer treatment, as it may disrupt signaling pathways that are often dysregulated in tumor cells. Additionally, its pharmacokinetic properties, such as solubility and bioavailability, are important for determining its suitability for clinical use. As with many investigational compounds, ongoing research is essential to fully understand its mechanism of action, therapeutic potential, and safety profile.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
CCT 137690
CAS:<p>CCT 137690 is a highly specific and oral-available aurora kinase inhibitor, for aurora A(IC50=15 nM ), B(IC50=25 nM) and C(IC50=19 nM).</p>Formula:C26H31BrN8OPurity:98.51% - 99.89%Color and Shape:SolidMolecular weight:551.48CCT137690
CAS:<p>CCT137690 is a chemical inhibitor, which is a synthetic compound developed through medicinal chemistry. Its primary mode of action is the selective inhibition of Cyclin-dependent kinases 8 and 19 (CDK8 and CDK19), which are part of the Mediator complex crucial for regulating transcription and gene expression. By interfering with these kinases, CCT137690 impacts the transcriptional regulation pathways that are critical for cancer cell proliferation and survival.</p>Formula:C26H31BrN8OPurity:Min. 95%Molecular weight:551.48 g/mol
